Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 419-720-5 | CAS number: 182061-89-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro data
Bacterial reverse mutation
Two studies are available to assess the potential of the test material to cause gene mutation in bacterial strains. Both studies were conducted in accordance with standardised guidelines OECD 471 and EU Method B.13/14. In the first study, reported by Molinier (1995), five strains of Salmonella typhimurium (TA1535, TA1537, TA98, TA100 and TA102) were treated in the presence and absence of a metabolic activation system (S9 mix). In two separate assays, the test material did not induce any significant, reproducible increases in the observed number of revertant colonies in any of the tester strains used in the presence or absence of metabolic activation.
In the second study, reported by de Joufrey (1996b), four trains of Salmonella typhimurium (TA1535, TA1537, TA98 and TA100) and one strain of Escherichia coli (WP2 uvr A) were treated in the presence and absence of a metabolic activation system (S9 mix). In two separate assays, the test material did not induce any significant, reproducible increases in the observed number of revertant colonies in any of the tester strains used in the presence or absence of metabolic activation.
Chromosome aberration test in vitro
The potential of the test material to induce structural chromosomal aberrations was determined in a study performed in accordance with standardised guidelines OECD 473 and EU Method B.10. The test material was tested in two independent experiments, both with and without S9 mix. No preliminary toxicity test was performed. A wide range of treatment levels was used for the first experiment and dose levels for scoring of chromosome aberrations were selected on the basis of cytotoxicity indicated by reduction of mitotic index. For each culture, heparinised whole blood was added to culture medium containing a mitogen and incubated at 39 ºC in a humidified atmosphere of 5 % CO2/ 95 % air, for 48 hours.
In the absence and presence of metabolic activation, no cytotoxicity was observed up to the highest applied concentration. In both experiments, no biologically relevant increase in the number of cells carrying structural chromosomal aberrations was observed after treatment with the test material. Appropriate mutagens were used as positive controls, which induced statistically significant increases (p < 0.05) in cells with structural chromosome aberrations. Under the specific conditions of this assay, the test material did not induce structural chromosomal aberrations as determined by the chromosome aberration test in human lymphocytes in vitro. Therefore, the test material is considered to be non-clastogenic in this chromosome aberration test in the absence and presence of metabolic activation.
All three studies presented to assess the genetic toxicity of the test material were performed in line with GLP and accepted standardised guidelines with a high standard of reporting. The studies were assigned a reliability score of 1 in accordance with the criteria for assessing data quality as outlined in Klimisch (1997) and considered suitable for assessment as an accurate reflection of the test material.
The available data are considered to be complete and the conclusion, non-mutagenic, was taken forward for risk assessment.
Justification for selection of genetic toxicity endpoint
All studies were considered together. A single study could not be selected as key; since the two Ames tests and the chromosome aberration test address different types of mutagenicity and are equally important in addressing this endpoint.
Short description of key information:
IN VITRO DATA
Reverse mutation in bacteria: Negative (S. typhimurium strains TA 1537, TA 1535, TA 100, TA 98 and TA 102 in the absence and presence of S9-mix), OECD 471, EU method B.14, Molinier 1995
Reverse mutation in bacteria: Negative (S. typhimurium strains TA 1537, TA 1535, TA 100 and TA 98 and E. coli strain WP2 uvr A in the absence and presence of S9-mix), OECD 471, EU method B.13/14, de Jouffrey 1996b
In vitro chromosome aberration: Negative, human lymphocytes with and without metabolic activation, OECD 473, EU method B.10, de Jouffrey 1996c
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
In accordance with criteria for classification as defined in Annex I, Regulation 1272/2008, the test material does not require classification for genetic toxicity based on the overall negative response noted in the available in vitro genetic toxicity studies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.